SG11201701109WA - Method for producing adult liver progenitor cells - Google Patents
Method for producing adult liver progenitor cellsInfo
- Publication number
- SG11201701109WA SG11201701109WA SG11201701109WA SG11201701109WA SG11201701109WA SG 11201701109W A SG11201701109W A SG 11201701109WA SG 11201701109W A SG11201701109W A SG 11201701109WA SG 11201701109W A SG11201701109W A SG 11201701109WA SG 11201701109W A SG11201701109W A SG 11201701109WA
- Authority
- SG
- Singapore
- Prior art keywords
- progenitor cells
- adult liver
- liver progenitor
- producing adult
- producing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
- C12N5/0672—Stem cells; Progenitor cells; Precursor cells; Oval cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/407—Liver; Hepatocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5067—Liver cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/12—Hepatocyte growth factor [HGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/73—Hydrolases (EC 3.)
- C12N2501/734—Proteases (EC 3.4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/54—Collagen; Gelatin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Developmental Biology & Embryology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Hematology (AREA)
- General Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2014/068317 WO2015028577A1 (en) | 2013-08-28 | 2014-08-28 | Method for producing adult liver progenitor cells |
| EP15157664 | 2015-03-04 | ||
| PCT/EP2015/069786 WO2016030525A1 (en) | 2014-08-28 | 2015-08-28 | Method for producing adult liver progenitor cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201701109WA true SG11201701109WA (en) | 2017-03-30 |
Family
ID=52705967
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201701109WA SG11201701109WA (en) | 2014-08-28 | 2015-08-28 | Method for producing adult liver progenitor cells |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US10538741B2 (en) |
| EP (1) | EP3140393B1 (en) |
| JP (2) | JP2017530697A (en) |
| KR (2) | KR102101060B1 (en) |
| CN (1) | CN106795489B (en) |
| AU (1) | AU2015308341B2 (en) |
| BR (1) | BR112017003996A2 (en) |
| CA (1) | CA2958851C (en) |
| DK (1) | DK3140393T3 (en) |
| EA (1) | EA035214B1 (en) |
| ES (1) | ES2954834T3 (en) |
| FI (1) | FI3140393T3 (en) |
| IL (1) | IL249232B (en) |
| LT (1) | LT3140393T (en) |
| MA (1) | MA39959A (en) |
| MX (1) | MX2017002667A (en) |
| PL (1) | PL3140393T3 (en) |
| PT (1) | PT3140393T (en) |
| SA (1) | SA517380984B1 (en) |
| SG (1) | SG11201701109WA (en) |
| WO (1) | WO2016030525A1 (en) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011140441A2 (en) | 2010-05-06 | 2011-11-10 | Children's Hospital Medical Center | Methods and systems for converting precursor cells into intestinal tissues through directed differentiation |
| EP3620514A1 (en) | 2013-08-28 | 2020-03-11 | Promethera Biosciences S.A. / N.V. | Method for producing adult liver progenitor cells |
| WO2015183920A2 (en) | 2014-05-28 | 2015-12-03 | Children's Hospital Medical Center | Methods and systems for converting precursor cells into gastric tissues through directed differentiation |
| WO2016061464A1 (en) | 2014-10-17 | 2016-04-21 | Children's Hospital Center, D/B/A Cincinnati Children's Hospital Medical Center | In vivo model of human small intetine using pluripotent stem cells and methods of making and using same |
| PT3140393T (en) | 2015-03-04 | 2023-09-04 | Cellaion Sa | Method for producing adult liver progenitor cells |
| CN116790476A (en) | 2016-05-05 | 2023-09-22 | 儿童医院医疗中心 | Methods for in vitro manufacturing of fundus tissue and compositions related thereto |
| WO2018106628A1 (en) | 2016-12-05 | 2018-06-14 | Children's Hospital Medical Center | Colonic organoids and methods of making and using same |
| EP3681520A4 (en) * | 2017-09-12 | 2021-07-07 | Beth Israel Deaconess Medical Center, Inc. | Compositions and methods for treating liver disease and dysfunction |
| JP7530886B2 (en) * | 2018-05-16 | 2024-08-08 | インセルム（インスティチュート ナショナル デ ラ サンテ エ デ ラ リシェルシェ メディカル） | Method for culturing proliferative hepatocytes |
| KR102107057B1 (en) * | 2018-09-21 | 2020-05-07 | 오가노이드사이언스 주식회사 | Method for preparing liver organoid comprising stem cell derived from liver and use thereof |
| CN110982776B (en) * | 2018-09-30 | 2023-07-04 | 中国科学院分子细胞科学卓越创新中心 | In-vitro amplification culture method and application of liver cells |
| TW202035682A (en) | 2018-12-14 | 2020-10-01 | 比利時商普羅米修亞生物科技股份有限公司 | Liver progenitor cells expressing hla-g, and method for obtaining these cells compositions comprising said cells and their use |
| EA202191673A1 (en) | 2018-12-14 | 2021-09-28 | Прометера Терапьютикс Са | CELL BASED COMPOSITION CONTAINING LIVER PRECEDOR CELLS EXPRESSING HLA-E |
| TW202100171A (en) | 2019-03-26 | 2021-01-01 | 比利時商普羅米修亞生物科技股份有限公司 | Adult liver progenitor cells for treating non-alcoholic fatty liver disease |
| EP3947644A1 (en) * | 2019-03-26 | 2022-02-09 | Promethera Therapeutics Sa | Adult liver progenitor cells for treating acute-on-chronic liver failure |
| US20220220445A1 (en) | 2019-04-30 | 2022-07-14 | Promethera Therapeutics Sa | Preparation of human allogeneic liver-derived progenitor cells |
| ES2966620T3 (en) | 2019-04-30 | 2024-04-23 | Cellaion Sa | Preparation of human allogeneic liver progenitor cells |
| CN110179970A (en) * | 2019-07-05 | 2019-08-30 | 浙江大学 | Application of the IL-1R2 cell factor in preparation treatment liver failure medicament |
| AU2020364951A1 (en) | 2019-10-09 | 2022-05-26 | Cellaïon SA | Use of liver progenitor or stem cells, lysates thereof, and/or conditioned medium in disorders characterized by vascular hyperpermeability |
| CN111206013A (en) * | 2020-02-13 | 2020-05-29 | 上海交通大学医学院附属仁济医院 | Culture method for maintaining functional state of human primary hepatocytes for long time |
| EP3881853A1 (en) | 2020-03-20 | 2021-09-22 | Promethera Therapeutics Sa | Human allogeneic liver-derived progenitor cells for use in the treatment of inflammatory and infectious lung diseases and systemic inflammation |
| WO2021260735A1 (en) * | 2020-06-26 | 2021-12-30 | Ykrita Lifesciences Private Limited | Bioengineered artificial lateral liver (ball) or bioengineered artificial ectopic liver (bael) |
| WO2023180122A1 (en) | 2022-03-24 | 2023-09-28 | Université Catholique de Louvain | Use of human allogenic liver-derived progenitor cells for treating and/or preventing cellular senescence |
| WO2024200809A1 (en) | 2023-03-31 | 2024-10-03 | Université Catholique de Louvain | Use of human allogenic liver-derived progenitor cells for treating and/or preventing hepatocellular carcinoma |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6129911A (en) | 1998-07-10 | 2000-10-10 | Rhode Island Hospital, A Lifespan Partner | Liver stem cell |
| US6872389B1 (en) | 1999-07-08 | 2005-03-29 | Rhode Island Hospital | Liver stem cell |
| JP2004510432A (en) | 2000-10-03 | 2004-04-08 | ユニバーシティ オブ ノース カロライナ | Method for isolating bipotent hepatic progenitor cells |
| SE527491C2 (en) | 2003-12-19 | 2006-03-21 | Cmc Contrast Ab | Contraceptive composition for magnetic resonance tomography for oral administration |
| CN101356264B (en) * | 2005-12-21 | 2014-05-14 | 鲁汶大学 | Isolated liver stem cells |
| WO2007071339A1 (en) * | 2005-12-21 | 2007-06-28 | Universite Catholique De Louvain | Isolated liver stem cells |
| US8415149B2 (en) * | 2010-05-06 | 2013-04-09 | Gwo Xi Stem Cell Applied Technology Co., Ltd. | Hepatic progenitor cells and uses thereof |
| DK3016665T3 (en) * | 2013-07-05 | 2019-11-25 | Univ Catholique Louvain | CONDITIONED MEDIUM FROM HUMAN ADULT LIVER STEM CELLS AND ITS USE IN THE TREATMENT OF HEALTH DISEASES |
| EP3620514A1 (en) | 2013-08-28 | 2020-03-11 | Promethera Biosciences S.A. / N.V. | Method for producing adult liver progenitor cells |
| PT3140393T (en) * | 2015-03-04 | 2023-09-04 | Cellaion Sa | Method for producing adult liver progenitor cells |
-
2015
- 2015-08-28 PT PT157597170T patent/PT3140393T/en unknown
- 2015-08-28 CN CN201580055411.3A patent/CN106795489B/en active Active
- 2015-08-28 FI FIEP15759717.0T patent/FI3140393T3/en active
- 2015-08-28 LT LTEPPCT/EP2015/069786T patent/LT3140393T/en unknown
- 2015-08-28 WO PCT/EP2015/069786 patent/WO2016030525A1/en active Application Filing
- 2015-08-28 AU AU2015308341A patent/AU2015308341B2/en active Active
- 2015-08-28 EA EA201790357A patent/EA035214B1/en not_active IP Right Cessation
- 2015-08-28 JP JP2017511583A patent/JP2017530697A/en active Pending
- 2015-08-28 KR KR1020167035465A patent/KR102101060B1/en active IP Right Grant
- 2015-08-28 SG SG11201701109WA patent/SG11201701109WA/en unknown
- 2015-08-28 CA CA2958851A patent/CA2958851C/en active Active
- 2015-08-28 MA MA039959A patent/MA39959A/en unknown
- 2015-08-28 US US15/315,032 patent/US10538741B2/en active Active
- 2015-08-28 PL PL15759717.0T patent/PL3140393T3/en unknown
- 2015-08-28 KR KR1020187038097A patent/KR20190003833A/en not_active Application Discontinuation
- 2015-08-28 BR BR112017003996A patent/BR112017003996A2/en not_active Application Discontinuation
- 2015-08-28 ES ES15759717T patent/ES2954834T3/en active Active
- 2015-08-28 EP EP15759717.0A patent/EP3140393B1/en active Active
- 2015-08-28 DK DK15759717.0T patent/DK3140393T3/en active
- 2015-08-28 MX MX2017002667A patent/MX2017002667A/en active IP Right Grant
-
2016
- 2016-11-27 IL IL249232A patent/IL249232B/en active IP Right Grant
-
2017
- 2017-02-27 SA SA517380984A patent/SA517380984B1/en unknown
-
2019
- 2019-11-26 US US16/695,444 patent/US11339373B2/en active Active
-
2020
- 2020-05-08 JP JP2020082331A patent/JP2020127423A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN106795489A (en) | 2017-05-31 |
| US20170240863A1 (en) | 2017-08-24 |
| JP2020127423A (en) | 2020-08-27 |
| BR112017003996A2 (en) | 2017-12-12 |
| CA2958851C (en) | 2023-05-09 |
| ES2954834T3 (en) | 2023-11-27 |
| MA39959A (en) | 2017-03-15 |
| DK3140393T3 (en) | 2023-09-18 |
| KR102101060B1 (en) | 2020-04-16 |
| KR20190003833A (en) | 2019-01-09 |
| AU2015308341A1 (en) | 2017-03-02 |
| CA2958851A1 (en) | 2016-03-03 |
| CN106795489B (en) | 2021-07-06 |
| IL249232B (en) | 2020-04-30 |
| US20200095554A1 (en) | 2020-03-26 |
| EP3140393B1 (en) | 2023-06-14 |
| EA035214B1 (en) | 2020-05-18 |
| JP2017530697A (en) | 2017-10-19 |
| LT3140393T (en) | 2023-09-11 |
| MX2017002667A (en) | 2017-10-02 |
| PL3140393T3 (en) | 2023-11-06 |
| AU2015308341B2 (en) | 2021-09-16 |
| PT3140393T (en) | 2023-09-04 |
| SA517380984B1 (en) | 2022-02-14 |
| EA201790357A1 (en) | 2017-08-31 |
| IL249232A0 (en) | 2017-02-28 |
| US11339373B2 (en) | 2022-05-24 |
| EP3140393A1 (en) | 2017-03-15 |
| FI3140393T3 (en) | 2023-09-07 |
| US10538741B2 (en) | 2020-01-21 |
| WO2016030525A1 (en) | 2016-03-03 |
| KR20170002664A (en) | 2017-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL249232A0 (en) | Method for producing adult liver progenitor cells | |
| IL244205A0 (en) | Method for producing adult liver progenitor cells | |
| SG11201701858SA (en) | Optimized method for producing methacrolein | |
| GB201418899D0 (en) | System for radiopharmaceutical production | |
| SG11201701945RA (en) | Process for making cyclohexanone | |
| SG11201701764WA (en) | Process for making cyclohexanone | |
| PT3199512T (en) | Method for preparing diol | |
| EP3227023B8 (en) | Method for producing drops | |
| SG11201701429SA (en) | Process for making cyclohexanone | |
| IL250099A0 (en) | Method for producing acetoin | |
| EP3237195A4 (en) | Methods for producing pressware | |
| PL3196196T3 (en) | Method for preparing calcobutrol | |
| IL257974A (en) | Method for producing renal progenitor cells | |
| IL252173A0 (en) | Method for producing methyl-dichloro-phosphane | |
| PT3237169T (en) | Method for producing moulded parts | |
| HK1247640A1 (en) | Method for producing high-quality ips cells | |
| SG11201701326YA (en) | Method for producing oligosilane | |
| EP3242937A4 (en) | Methods for producing abienol | |
| PL3177602T3 (en) | Method for preparing trioxane | |
| EP3184616A4 (en) | Method for producing monoglyceride-containing composition | |
| EP3162786A4 (en) | Method for producing 4-isopropyl-3-methylphenol | |
| EP3111497A4 (en) | Molding process for making fuel cell components | |
| ZA201606983B (en) | Method for mixed biomass hydrolysis | |
| HUE052742T2 (en) | Method for producing parts | |
| ZA201700478B (en) | Method for producing 2-amino-6-methylnicotinic acid |